https://www.marketscreener.com/quote/stock/JHL-BIOTECH-INC-27329662/news/Jhl-Biotech-Announces-China-Approves-Clinical-Trial-Rituximab-Biosimilar-to-Treat-Non-Hodgkin-Lympho-34656145/?utm_source=telegram&utm_medium=social&utm_campaign=share